Long Beach, CALIFORNIA10 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Long Beach, CALIFORNIA

Find 10 actively recruiting myalgic encephalomyelitis clinical trials in Long Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
37,129
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Long Beach

RecruitingLong Beach, CALIFORNIANCT04262206

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in com...

20,000 participants
Duke University
View Study Details
RecruitingLong Beach, CALIFORNIANCT07177352

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies....

13,000 participants
Hoffmann-La Roche
View Study Details
RecruitingLong Beach, CALIFORNIANCT06653153

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study ...

1,400 participants
Eli Lilly and Company
View Study Details
RecruitingLong Beach, CALIFORNIANCT06054555

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

The purpose of this study is to assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma....

620 participants
Amgen
View Study Details
RecruitingLong Beach, CALIFORNIANCT06976216

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...

586 participants
Bristol-Myers Squibb
View Study Details
RecruitingLong Beach, CALIFORNIANCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD....

406 participants
Karuna Therapeutics
View Study Details
RecruitingLong Beach, CALIFORNIANCT07011745

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease....

352 participants
Bristol-Myers Squibb
View Study Details
RecruitingLong Beach, CALIFORNIANCT07033494

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Researchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). AD is a type of dementia that can cause loss of memo...

340 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingLong Beach, CALIFORNIANCT05382338

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers t...

225 participants
Children's Oncology Group
View Study Details
RecruitingLong Beach, CALIFORNIANCT06701682

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute...

200 participants
PPD Development, LP
View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Long Beach

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 10 myalgic encephalomyelitis clinical trials recruiting participants in Long Beach, CALIFORNIA. These studies are seeking a combined 37,129 participants. Research is being sponsored by Duke University, Hoffmann-La Roche, Eli Lilly and Company and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Long Beach — FAQ

Are there myalgic encephalomyelitis clinical trials in Long Beach?

Yes, there are 10 myalgic encephalomyelitis clinical trials currently recruiting in Long Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Long Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.

Are clinical trials in Long Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 10 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated March 2, 2026 from ClinicalTrials.gov